Global Healthcare ETF - Currency Hedged | BetaShares
  • Request info pack
  • Download factsheet
  • Request a call
  • Request Lonsec research

Thank you for your request, an email will be sent to you shortly. If you don’t receive it within 30 minutes please contact info@betashares.com.au

OVERVIEW

About

Provides simple, cost-effective and transparent exposure to the largest companies in the global healthcare sector

  • Tactical exposure to the global healthcare sector
  • A core component of a global equities allocation providing transparency and diversification benefits

Advantages

  • Access – simple way to access a diversified portfolio of the world’s largest healthcare companies
  • Reduced currency risk – foreign currency exposure hedged to the Australian dollar
  • Diversification – with a single trade, investors can get exposure to a diversified portfolio of healthcare companies from a broad range of global locations
  • Cost effective – Fund aims to track the performance of an index (no ‘active manager’ fees)
  • Large company exposure – strategy invests only in the most significant healthcare companies globally
  • No W-8 BEN forms and no US estate tax implications for investors – simplified tax administration, unlike cross-listed alternatives
  • Liquidity – available to trade on ASX like any share

How to Invest

  • You can buy or sell units just like you’d buy or sell any share on the ASX
  • Fund requires no minimum investment

KEY FACTS

Pricing Information 22 May 2019

Current Price
Last Trade* $5.73
% Change (prev day) 0%
Bid (delayed) $5.74
Offer (delayed) $5.80
*Data is delayed by at least 20 minutes.
Download NAV history
NAV
NAV/Unit * $5.70
* As at 20 May 2019

Profile

Net Assets* ($A) $29,706,502
Units Outstanding* (#) 5,210,204
Mgmt Costs** (% p.a.) 0.57%
Distribution Frequency Semi-annual
Distribution Reinvestment Plan (DRP) Full or partial participation available
Issuer BetaShares Capital Ltd
Fund Administrator RBC Investor Services
Custodian RBC Investor Services
Registry Link Market Services
Auditor KPMG
* As at 20 May 2019
**Certain additional costs apply. Please refer to PDS.

Trading Information

ASX Code DRUG
Bloomberg Code DRUG AU
IRESS Code DRUG.AXW
Trading Hours 10.00-16.00 (AEST)
iNAV IRESS Code N/A
Market Makers Deutsche Securities
SMSF Eligible Yes

Index Information

Index Nasdaq Global ex-Australia Healthcare Hedged AUD Index
Index Provider Nasdaq
Index Ticker N/A
Bloomberg Index Ticker NQXAUHHN INDEX
Index Methodology

Portfolio Holdings

Name Weight (%)
JOHNSON & JOHNSON 8.5
UNITEDHEALTH GROUP INC 5.9
PFIZER INC 5.7
NOVARTIS AG 5.6
MERCK & CO INC 5.2
ROCHE HOLDING AG 4.0
ABBOTT LABORATORIES 3.4
MEDTRONIC PLC 3.0
ELI LILLY & CO 2.9
ABBVIE INC 2.8
Ticker Name Weight (%) Asset Class Sector Country Currency Shares/Unit (#) Market Value (AUD) Notional Value (AUD)
JNJ UN JOHNSON & JOHNSON 8.5 Equities Healthcare United States USD 12,781 $2,559,899 $2,559,899
UNH UN UNITEDHEALTH GROUP INC 5.9 Equities Healthcare United States USD 4,998 $1,778,987 $1,778,987
PFE UN PFIZER INC 5.7 Equities Healthcare United States USD 28,610 $1,721,733 $1,721,733
NOVN SW NOVARTIS AG 5.6 Equities Healthcare Switzerland CHF 14,287 $1,700,130 $1,700,130
MRK UN MERCK & CO INC 5.2 Equities Healthcare United States USD 13,735 $1,567,670 $1,567,670
ROG SW ROCHE HOLDING AG 4.0 Equities Healthcare Switzerland CHF 3,137 $1,197,138 $1,197,138
ABT UN ABBOTT LABORATORIES 3.4 Equities Healthcare United States USD 9,382 $1,028,613 $1,028,613
MDT UN MEDTRONIC PLC 3.0 Equities Healthcare United States USD 7,096 $899,142 $899,142
LLY UN ELI LILLY & CO 2.9 Equities Healthcare United States USD 5,293 $890,183 $890,183
ABBV UN ABBVIE INC 2.8 Equities Healthcare United States USD 7,456 $861,146 $861,146
GSK LN GLAXOSMITHKLINE PLC 2.5 Equities Healthcare Britain GBP 26,519 $757,658 $757,658
TMO UN THERMO FISHER SCIENTIFIC INC 2.5 Equities Healthcare United States USD 1,949 $741,443 $741,443
AMGN UW AMGEN INC 2.4 Equities Healthcare United States USD 3,003 $731,696 $731,696
SAN FP SANOFI 2.4 Equities Healthcare France EUR 6,090 $731,627 $731,627
NOVOB DC NOVO NORDISK A/S 2.3 Equities Healthcare Denmark DKK 10,106 $692,917 $692,917
AZN LN ASTRAZENECA PLC 2.2 Equities Healthcare Britain GBP 6,331 $679,025 $679,025
GILD UW GILEAD SCIENCES INC 2.0 Equities Healthcare United States USD 6,479 $617,432 $617,432
BMY UN BRISTOL-MYERS SQUIBB CO 1.9 Equities Healthcare United States USD 8,627 $578,088 $578,088
ANTM UN ANTHEM INC 1.7 Equities Healthcare United States USD 1,354 $521,753 $521,753
SYK UN STRYKER CORP 1.6 Equities Healthcare United States USD 1,810 $482,710 $482,710
CI UN CIGNA CORP 1.5 Equities Healthcare United States USD 2,004 $445,601 $445,601
BAYN GY BAYER AG 1.5 Equities Healthcare Germany EUR 4,933 $444,432 $444,432
4502 JT TAKEDA PHARMACEUTICAL CO LTD 1.5 Equities Healthcare Japan JPY 8,400 $442,175 $442,175
BDX UN BECTON DICKINSON AND CO 1.4 Equities Healthcare United States USD 1,251 $415,178 $415,178
ISRG UW INTUITIVE SURGICAL INC 1.3 Equities Healthcare United States USD 553 $386,660 $386,660
ZTS UN ZOETIS INC 1.2 Equities Healthcare United States USD 2,541 $375,837 $375,837
AGN UN ALLERGAN PLC 1.2 Equities Healthcare United States USD 1,803 $362,061 $362,061
BSX UN BOSTON SCIENTIFIC CORP 1.1 Equities Healthcare United States USD 6,385 $344,518 $344,518
BIIB UW BIOGEN INC 1.1 Equities Healthcare United States USD 986 $329,228 $329,228
PHIA NA KONINKLIJKE PHILIPS NV 1.0 Equities Healthcare Netherlands EUR 5,212 $304,735 $304,735
ILMN UW ILLUMINA INC 1.0 Equities Healthcare United States USD 700 $304,461 $304,461
BAX UN BAXTER INTERNATIONAL INC 1.0 Equities Healthcare United States USD 2,755 $300,256 $300,256
EL FP ESSILORLUXOTTICA SA 1.0 Equities Consumer Discretionary France EUR 1,671 $292,857 $292,857
HCA UN HCA HEALTHCARE INC 0.9 Equities Healthcare United States USD 1,549 $281,716 $281,716
EW UN EDWARDS LIFESCIENCES CORP 0.9 Equities Healthcare United States USD 1,117 $279,258 $279,258
VRTX UW VERTEX PHARMACEUTICALS INC 0.9 Equities Healthcare United States USD 1,121 $268,823 $268,823
4568 JT DAIICHI SANKYO CO LTD 0.8 Equities Healthcare Japan JPY 3,400 $244,460 $244,460
HUM UN HUMANA INC 0.8 Equities Healthcare United States USD 656 $237,331 $237,331
7741 JP HOYA CORP 0.7 Equities Healthcare Japan JPY 2,100 $217,995 $217,995
4503 JT ASTELLAS PHARMA INC 0.7 Equities Healthcare Japan JPY 10,600 $210,358 $210,358
IQV UN IQVIA HOLDINGS INC 0.7 Equities Healthcare United States USD 1,035 $200,186 $200,186
ALGN UW ALIGN TECHNOLOGY INC 0.6 Equities Healthcare United States USD 415 $191,965 $191,965
REGN UW REGENERON PHARMACEUTICALS INC 0.6 Equities Healthcare United States USD 431 $188,696 $188,696
LONN SW LONZA GROUP AG 0.6 Equities Healthcare Switzerland CHF 419 $186,683 $186,683
ZBH UN ZIMMER BIOMET HOLDINGS INC 0.6 Equities Healthcare United States USD 1,090 $182,829 $182,829
FRE GY FRESENIUS SE & CO KGAA 0.6 Equities Healthcare Germany EUR 2,327 $176,631 $176,631
ALXN UW ALEXION PHARMACEUTICALS INC 0.6 Equities Healthcare United States USD 954 $175,629 $175,629
4543 JT TERUMO CORP 0.5 Equities Healthcare Japan JPY 3,800 $159,166 $159,166
IDXX UW IDEXX LABORATORIES INC 0.5 Equities Healthcare United States USD 437 $157,158 $157,158
CNC UN CENTENE CORP 0.5 Equities Healthcare United States USD 1,898 $152,450 $152,450
4578 JT OTSUKA HOLDINGS CO LTD 0.5 Equities Healthcare Japan JPY 2,800 $143,306 $143,306
4507 JT SHIONOGI & CO LTD 0.4 Equities Healthcare Japan JPY 1,600 $134,939 $134,939
4523 JT EISAI CO LTD 0.4 Equities Healthcare Japan JPY 1,600 $134,497 $134,497
FME GY FRESENIUS MEDICAL CARE AG & CO 0.4 Equities Healthcare Germany EUR 1,209 $133,404 $133,404
INCY UW INCYTE CORP 0.4 Equities Healthcare United States USD 1,153 $128,180 $128,180
4519 JT CHUGAI PHARMACEUTICAL CO LTD 0.4 Equities Healthcare Japan JPY 1,300 $123,567 $123,567
COLOB DC COLOPLAST A/S 0.4 Equities Healthcare Denmark DKK 769 $118,797 $118,797
068270 KS CELLTRION INC 0.3 Equities Healthcare South Korea KRW 441 $100,552 $100,552
BMRN UW BIOMARIN PHARMACEUTICAL INC 0.3 Equities Healthcare United States USD 779 $97,682 $97,682
207940 KP SAMSUNG BIOLOGICS CO LTD 0.1 Equities Healthcare South Korea KRW 93 $33,104 $33,104
USD USD - United States Dollar 0.1 Cash USD 20,923 $30,274 $30,274
JPY JPY - Japanese Yen 0.1 Cash JPY 1,294,140 $17,014 $17,014
GBP GBP - British Pound 0.0 Cash GBP 6,022 $11,091 $11,091
EUR EUR - Euro 0.0 Cash EUR 5,056 $8,171 $8,171
AUD AUD - Australia Dollar 0.0 Cash AUD 2,492 $2,492 $2,492
CHF CHF - Swiss Franc 0.0 Cash CHF 796 $1,142 $1,142
DKK DKK - Danish Krone 0.0 Cash DKK 2,831 $613 $613
CAD CAD - Canada Dollar 0.0 Cash CAD 133 $143 $143
KRW KRW - Korean Won Cash KRW 0 $0 $0
AUD AUD - Australia Dollar FX Forwards AUD 29,676,633 $29,676,633
CHF CHF - Swiss Franc FX Forwards CHF -2,144,535 -$3,077,249
DKK DKK - Danish Krone FX Forwards DKK -3,891,035 -$841,869
EUR EUR - Euro FX Forwards EUR -1,346,594 -$2,176,138
GBP GBP - British Pound FX Forwards GBP -784,986 -$1,445,620
JPY JPY - Japanese Yen FX Forwards JPY -139,039,643 -$1,827,930
USD USD - United States Dollar FX Forwards USD -14,421,007 -$20,866,744
Download CSV
* As at 20 May 2019

Sector Allocation

Healthcare
100.0%
* As of 30 April 2019

Country Allocation

United States
68.8%
Switzerland
10.1%
Japan
5.9%
Britain
4.8%
France
3.5%
Denmark
2.7%
Germany
2.7%
Netherlands
1.0%
South Korea
0.5%
* As of 30 April 2019

PERFORMANCE

Fund Returns After Fees (%)

  Fund Index
1 month -2.66% -3.36%
3 months 0.68% 0.02%
6 months 0.98% 0.51%
1 year 9.73% 9.52%
3 year p.a - -
5 year p.a - -
Since inception (p.a) 6.81% 6.96%
Inception date 4-Aug-16 -
* As at 30 April 2019

Chart

Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.

DISTRIBUTIONS

Yield Information

Distribution Frequency Semi-Annual
12 Mth Distribution Yield* (%) 3.5%
12 Mth Gross Distribution Yield* (%) -
Franking Level -
*As at 30 April 2019. Yield figures are calculated by summing the prior 12 month net and gross fund per unit distributions divided by the fund closing NAV per unit. Past performance is not an indicator of future performance.

Recent Distributions

Ex Date Record Date Payment Date Distribution Unit ($) Annual Distribution Return (%) (1)
2-Jan-19 3-Jan-19 17-Jan-19 $0.01869 3.71%
2-Jul-18 3-Jul-18 17-Jul-18 $0.18445 3.77%
2-Jan-18 3-Jan-18 17-Jan-18 $0.01646 0.35%
View more
1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. It is calculated as the difference between total Fund return and NAV return. NAV return is the change in the Fund's NAV price. Total return is the NAV return plus reinvestment of all distributions back to the Fund. Past performance not indicative of future performance.

ANNOUNCEMENTS

ASX Announcements: DRUG

Download
Showing - of

RESOURCES

Factsheet - DRUG
Download
Fund Flyer - DRUG
Download
Portfolio Holdings
Download
The Investment Case for DRUG
Download
Product Disclosure Statement - Global Sector Series
Download
Annual Report - June 2018
Download
NRWT and Fund Payment Notice information – December 2018 distributions
Download
Notice of Modifications to Fund Constitution – AMIT Tax Regime
Download
Index Methodology
Download
2018 Distribution Calendar
Download
Interim Financial Report 2018
Download
View more

LEARN MORE ABOUT DRUG

Request an info pack